Showing 1 - 13 results of 13 for search 'Hyang-Sook Hoe', query time: 0.05s Refine Results
  1. 1
    Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling

    Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling by Hyun-ju Lee, Hyang-Sook Hoe

    Published 2023-04-01
    Get full text
    Article
  2. 2
    EGFR is a potential dual molecular target for cancer and Alzheimer’s disease

    EGFR is a potential dual molecular target for cancer and Alzheimer’s disease by Hee-Jeong Choi, Yoo Joo Jeong, Yoo Joo Jeong, Jieun Kim, Jieun Kim, Hyang-Sook Hoe, Hyang-Sook Hoe

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A

    Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A by Jieun Kim, Su-Jin Kim, Ha-Ram Jeong, Jin-Hee Park, Jin-Hee Park, Minho Moon, Hyang-Sook Hoe, Hyang-Sook Hoe

    Published 2022-10-01
    Get full text
    Article
  4. 4
    Mesoscopic Mapping of Visual Pathway in a Female 5XFAD Mouse Model of Alzheimer’s Disease

    Mesoscopic Mapping of Visual Pathway in a Female 5XFAD Mouse Model of Alzheimer’s Disease by Yunkwon Nam, Sujin Kim, Jieun Kim, Hyang-Sook Hoe, Minho Moon

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β

    Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β by Jin-Hee Park, Jin-Hee Park, Jeong-Woo Hwang, Hyun-ju Lee, Geum Mi Jang, Yoo Joo Jeong, Yoo Joo Jeong, Joonho Cho, Jinsoo Seo, Hyang-Sook Hoe, Hyang-Sook Hoe

    Published 2023-06-01
    Get full text
    Article
  6. 6
    Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD

    Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD by Hyun-ju Lee, Hyun-ju Lee, Jeong-Woo Hwang, Jeong-Woo Hwang, Jieun Kim, A-Ran Jo, A-Ran Jo, Jin-Hee Park, Yoo Joo Jeong, Yoo Joo Jeong, Yoo Joo Jeong, Ji-Yeong Jang, Ji-Yeong Jang, Ji-Yeong Jang, Su-Jeong Kim, Jeong-Heon Song, Hyang-Sook Hoe, Hyang-Sook Hoe, Hyang-Sook Hoe

    Published 2024-10-01
    Get full text
    Article
  7. 7
    Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy

    Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy by Jieun Kim, Jung-Youn Han, Yujeong Lee, Kipom Kim, Young Pyo Choi, Sehyun Chae, Hyang-Sook Hoe

    Published 2023-01-01
    Get full text
    Article
  8. 8
    Profiling tyrosine kinase inhibitors as AD therapeutics in a mouse model of AD

    Profiling tyrosine kinase inhibitors as AD therapeutics in a mouse model of AD by Hyun-ju Lee, Jeong-Woo Hwang, Jin-Hee Park, Yoo Joo Jeong, Ji-Yeong Jang, Hyang-Sook Hoe

    Published 2023-08-01
    Get full text
    Article
  9. 9
    Felodipine attenuates neuroinflammatory responses and tau hyperphosphorylation through JNK/P38 signaling in tau-overexpressing AD mice

    Felodipine attenuates neuroinflammatory responses and tau hyperphosphorylation through JNK/P38 signaling in tau-overexpressing AD mice by Jeong-Woo Hwang, Jeongha Kim, Jin-Hee Park, Jinhan Nam, Ji-Yeong Jang, Aran Jo, Hyun-ju Lee, Hyang-Sook Hoe

    Published 2024-09-01
    Get full text
    Article
  10. 10
    L-DOPA regulates neuroinflammation and Aβ pathology through NEP and ADAM17 in a mouse model of AD

    L-DOPA regulates neuroinflammation and Aβ pathology through NEP and ADAM17 in a mouse model of AD by Hyun-ju Lee, JinHan Nam, Jeong-Woo Hwang, Jin-Hee Park, Yoo Joo Jeong, Ji-Yeong Jang, Su-Jeong Kim, A-Ran Jo, Hyang-Sook Hoe

    Published 2024-04-01
    Get full text
    Article
  11. 11
    Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD

    Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD by Kyung-Min Han, Ri Jin Kang, Hyongjun Jeon, Hyun-ju Lee, Ji-Soo Lee, HyunHee Park, Seong Gak Jeon, Kyoungho Suk, Jinsoo Seo, Hyang-Sook Hoe

    Published 2020-07-01
    Get full text
    Article
  12. 12
    The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD

    The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD by HyunHee Park, Kyung-Min Han, Hyongjun Jeon, Ji-Soo Lee, Hyunju Lee, Seong Gak Jeon, Jin-Hee Park, Yu Gyung Kim, Yuxi Lin, Young-Ho Lee, Yun Ha Jeong, Hyang-Sook Hoe

    Published 2020-08-01
    Get full text
    Article
  13. 13
    The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta

    The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta by Sehyun Chae, Hyun-ju Lee, Ha-Eun Lee, Jieun Kim, Yoo Joo Jeong, Yuxi Lin, Hye Yun Kim, Geoffray Leriche, Rachel S. Ehrlich, Sascha Castro Lingl, Min-Duk Seo, Young-Ho Lee, Jerry Yang, Jae-Ick Kim, Hyang-Sook Hoe

    Published 2024-08-01
    Get full text
    Article

Search Tools: